A detailed history of Financial Advisory Group transactions in Avita Medical, Inc. stock. As of the latest transaction made, Financial Advisory Group holds 15,521 shares of RCEL stock, worth $178,181. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,521
Previous 13,021 19.2%
Holding current value
$178,181
Previous $178,000 39.33%
% of portfolio
0.04%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$12.56 - $18.31 $31,400 - $45,775
2,500 Added 19.2%
15,521 $248,000
Q4 2023

Feb 13, 2024

SELL
$9.29 - $14.57 $46,449 - $72,850
-5,000 Reduced 27.75%
13,021 $178,000
Q3 2023

Dec 07, 2023

BUY
$13.84 - $20.79 $12,594 - $18,918
910 Added 5.32%
18,021 $263,000
Q1 2023

May 11, 2023

BUY
$6.45 - $14.48 $31,701 - $71,169
4,915 Added 40.3%
17,111 $239,000
Q4 2022

Feb 09, 2023

BUY
$4.53 - $7.55 $9,209 - $15,349
2,033 Added 20.0%
12,196 $80,000
Q3 2022

Nov 14, 2022

BUY
$4.97 - $7.89 $50,510 - $80,186
10,163 New
10,163 $54,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $287M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Financial Advisory Group Portfolio

Follow Financial Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Group with notifications on news.